Simple exercise program may shield breast cancer patients from nerve damage

NCT ID NCT04583124

Completed Symptom relief Sponsor: Universidad de Granada Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a program of therapeutic exercise and relaxation techniques (called ATENTO) could prevent nerve damage (neurotoxicity) in women newly diagnosed with breast cancer. 42 women were split into two groups: one started the program before cancer treatment, the other during treatment. Researchers measured quality of life and cognitive function to see which timing worked best.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: therapeutic exercise and vagal activation techniques
What this could lead to: If it works, this could point toward a simple, drug-free way to prevent nerve damage from cancer treatment, improving quality of life for breast cancer patients.
What could go wrong: This is a very small, early study with only 42 participants, so results may not apply to everyone. The intervention is not a treatment for cancer itself, only for side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm toxic encephalopathy prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST NEOPLASM

Contacts and locations

Locations

University of Granada

Granada, 18016, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.